Quantitative ELISA for SERPINA4/kallistatin

Area of Science:

• Biochemistry
• Clinical Chemistry
• Immunology

Background:

• SERPINA4/kallistatin is a multifunctional protein primarily synthesized in the liver.
• Its circulating levels correlate with liver dysfunction, suggesting potential as a biomarker for chronic liver diseases (CLD).

Purpose of the Study:

• To develop and validate an enzyme-linked immunosorbent assay (ELISA) for quantifying SERPINA4/kallistatin.
• To assess the diagnostic utility of SERPINA4/kallistatin levels in patients with CLD.

Main Methods:

• Development of a quantitative ELISA using specific antibodies against SERPINA4/kallistatin.
• Western blot analysis to confirm antibody specificity and rule out interference from other SERPINs.
• Assay validation including precision, linearity, and comparison between CLD patients and healthy controls.

Main Results:

• A specific and quantitative ELISA for SERPINA4/kallistatin was successfully developed.
• Reduced serum levels of SERPINA4/kallistatin were observed in patients with CLD compared to healthy individuals.
• The developed ELISA demonstrated good accuracy, precision, and linearity.

Conclusions:

• The developed ELISA is a reliable tool for measuring SERPINA4/kallistatin levels.
• Lower SERPINA4/kallistatin concentrations in CLD patients highlight its potential as a diagnostic and prognostic biomarker.
• Further studies are warranted to explore its clinical application in managing chronic liver diseases.